Weekly Chest CasesArchive of Old Cases

Case No : 338 Date 2004-04-17

  • Courtesy of Hyae Young Kim, M.D. / National Cancer center, Seoul, Korea
  • Age/Sex 40 / F
  • Chief ComplaintHemoptysis. History of right mastectomy for right breast cancer
  • Figure 1
  • Figure 2

Diagnosis With Brief Discussion

Diagnosis
Typical carcinoid
Radiologic Findings
Pre-enhanced CT scan shows a well-defined lobulated contoured soft tissue mass without calcification in left lower lobe. Post-enhanced CT scan reveals heterogenous well-enhancing mass within the left lower lobe bronchus. PET scan reveals irregular moderate hypermetabolic activity in posterior aspect of left lower lobe (SUVp:3.4), which is in the atelectatic lung not in the mass. The patient had right mastectomy and presented with recent history of intermittent blood tinged sputum. Differential diagnosis included endobronchial metastasis, lung cancer and other endobronchial tumor, such as carcinoid. Carcinoid tumor was confirmed by PCNB. Previous chest CT scan was reviewed and the patient has the tumor since three years without interval change.
Brief Review
Carcinoid tumor is a low-grade malignant tumor, only aout 0.5% to 2.5% of all pulmonary neoplasm. Typical carcinoid represents 80% to 90% of carcinoid tumors. Typical carcinoids tend to be more central and to be smaller at presentation. Sixteen to 40 % are peripheral; the others are central. Centrally located bronchial carcinoids may e predominantly intraluminal. Assuming a polypoid configuration, may grow along the lumen of the bronchus, or may be predominantly extraluminal, in which case they are known as ‘iceberg’ lesions.

CT scan usually shows the anatomic relationship of the central mass with the bronchus. Small tumors in segmental and subsegmental bronchi may result in mucous distension of the bronchi beyond the obstruction. Because bronchial carcinoid tumors are very vascular, marked enhancement may be seen following IV administration of contrast medium. On FDG PET, pulmonary carcinoid tumors usually have lower FDG uptake than expected for malignant tumors.
References
1. Foster BB, Muller NL, Miller PR, Nelems B, Evans KG. Neuroendocrine carcinoma of the lung: clinical, radiologic, and pathologic correlation. Radiology 1989;170:441-445.

2. Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR 1998;170:1369-73.

3. Fraser RS, Muller NL, Colman N, Pare PD. Diagnosis of diseases of the chest. 4th ed. Saunders: Philadelphia, 1999;1229-1243.
Keywords
Airway, Malignant tumor,

No. of Applicants : 23

▶ Correct Answer : 10/23,  43.5%
  • - Centre d'imagerie Jacques Callot, Nancy, France Lionel Cannard
  • - CHU Nancy-Brabois, France Denis Regent
  • - CIM Saint Dizier, France JC Leclerc
  • - Dong-A University Hospital, Korea Ki-Nam Lee
  • - Escola Paulista de Medicina, Fleury, Sao Paulo, Brazil Gustavo Meirelles
  • - Hangang Sacred Heart Hospital, Korea Eil Seong Lee
  • - Kangbuk Samsung Hospital, Korea Hyon Joo Kwag
  • - Mallinckrodt Institute of Radiology, USA Jin Mo Goo
  • - National Taiwan University Hospital, Taiwan Tan Che Kim
  • - Nowon Eulji hospital, Korea Jeong Joo Woo
  • Top
  • Back

Each Case of This Site Supplied by the Members of KSTR.
Copyright of the Images is in the KSTR and Original Supplier.
Current Editor : Sang Young Oh, M.D., Ph.D Email : sangyoung.oh@gmail.com

This website is optimized for IE 10 and above.